X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6686) 6686
Publication (488) 488
Book Review (486) 486
Newsletter (143) 143
Book Chapter (22) 22
Conference Proceeding (19) 19
Newspaper Article (13) 13
Magazine Article (10) 10
Dissertation (5) 5
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5090) 5090
humans (3932) 3932
ceftazidime (3367) 3367
microbiology (1931) 1931
male (1863) 1863
female (1816) 1816
pharmacology & pharmacy (1668) 1668
microbial sensitivity tests (1595) 1595
ceftazidime - pharmacology (1479) 1479
ceftazidime - therapeutic use (1398) 1398
infectious diseases (1375) 1375
anti-bacterial agents - pharmacology (1288) 1288
adult (1263) 1263
middle aged (1220) 1220
antibiotics (1105) 1105
anti-bacterial agents - therapeutic use (1049) 1049
aged (975) 975
pseudomonas aeruginosa - drug effects (731) 731
infections (725) 725
ceftazidime - administration & dosage (685) 685
adolescent (668) 668
cephalosporins - pharmacology (663) 663
resistance (574) 574
animals (561) 561
cephalosporins - therapeutic use (536) 536
beta-lactamases - genetics (525) 525
beta-lactamases - metabolism (524) 524
child (505) 505
bacterial infections - drug therapy (495) 495
anti-bacterial agents - administration & dosage (488) 488
bacteria (484) 484
treatment outcome (484) 484
escherichia-coli (482) 482
pseudomonas infections - drug therapy (478) 478
pseudomonas aeruginosa (477) 477
drug therapy, combination (455) 455
pseudomonas-aeruginosa (440) 440
drug resistance, microbial (436) 436
cephalosporins (426) 426
enterobacteriaceae (418) 418
cefepime (398) 398
pharmacokinetics (396) 396
prospective studies (391) 391
ciprofloxacin (389) 389
therapy (387) 387
aged, 80 and over (382) 382
imipenem (381) 381
klebsiella-pneumoniae (373) 373
escherichia coli - drug effects (365) 365
drug resistance (360) 360
meropenem (348) 348
abridged index medicus (343) 343
child, preschool (341) 341
gram-negative bacteria (337) 337
cefotaxime (332) 332
immunology (330) 330
research (324) 324
oncology (323) 323
ceftazidime - pharmacokinetics (319) 319
infection (319) 319
fever (304) 304
gram-negative bacteria - drug effects (298) 298
epidemiology (297) 297
antimicrobial agents (288) 288
pneumonia (287) 287
susceptibility (287) 287
infant (285) 285
ceftazidime - adverse effects (283) 283
health aspects (283) 283
klebsiella pneumoniae - drug effects (283) 283
amikacin (282) 282
drug resistance, bacterial (282) 282
cefotaxime - pharmacology (272) 272
risk factors (270) 270
hospitals (266) 266
enterobacteriaceae - drug effects (263) 263
drug therapy, combination - therapeutic use (262) 262
kinetics (262) 262
pediatrics (262) 262
anti-bacterial agents - pharmacokinetics (260) 260
pseudomonas infections - microbiology (259) 259
biochemical phenomena, metabolism, and nutrition (256) 256
ceftriaxone (249) 249
imipenem - pharmacology (249) 249
retrospective studies (249) 249
bacteremia (245) 245
antimicrobial resistance (243) 243
bacteria - drug effects (243) 243
gentamicin (243) 243
medicine, general & internal (243) 243
infusions, intravenous (241) 241
ceftazidime-avibactam (240) 240
drug therapy (240) 240
cephalosporins - administration & dosage (238) 238
vancomycin (238) 238
drug resistance in microorganisms (236) 236
strains (232) 232
cross infection - microbiology (228) 228
time factors (226) 226
escherichia coli - genetics (225) 225
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6194) 6194
French (215) 215
Japanese (131) 131
Spanish (67) 67
German (62) 62
Chinese (56) 56
Italian (56) 56
Russian (32) 32
Polish (21) 21
Turkish (19) 19
Romanian (6) 6
Croatian (5) 5
Czech (5) 5
Hungarian (4) 4
Korean (4) 4
Portuguese (4) 4
Slovak (3) 3
Danish (2) 2
Dutch (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Finnish (1) 1
Indonesian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Antimicrobial Agents, ISSN 0924-8579, 04/2010, Volume 35, Issue 4, pp. 412 - 413
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 06/2016, Volume 62, Issue 11, pp. 1380 - 1389
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 754 - 762
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE... 
acute pyelonephritis | ceftazidime-avibactam | complicated urinary tract infection | INFECTIOUS DISEASES | INITIAL ANTIBIOTIC-THERAPY | ANTIMICROBIAL THERAPY | MICROBIOLOGY | IMMUNOLOGY | INTRAABDOMINAL INFECTION | CARBAPENEM-RESISTANT ENTEROBACTERIACEAE | TREATMENT OPTIONS | BACTERICIDAL ACTIVITY | PSEUDOMONAS-AERUGINOSA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | KLEBSIELLA-PNEUMONIAE | Doripenem | Azabicyclo Compounds - administration & dosage | Carbapenems - administration & dosage | Humans | Middle Aged | Male | Pyelonephritis - complications | Urinary Tract Infections - complications | Urinary Tract Infections - drug therapy | Carbapenems - adverse effects | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Ceftazidime - administration & dosage | Adult | Azabicyclo Compounds - therapeutic use | Female | Aged | Anti-Bacterial Agents - adverse effects | Ceftazidime - adverse effects | Pyelonephritis - drug therapy | Anti-Bacterial Agents - administration & dosage | Ceftazidime - therapeutic use | Drug Combinations | Azabicyclo Compounds - adverse effects | Care and treatment | Usage | Pyelonephritis | Clinical trials | Urinary tract infections | Influence | Dosage and administration | Ceftazidime | Antibiotics | Drug resistance | Drug therapy | CRE bacteria | Urinary tract diseases | Index Medicus | and Commentaries
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2018, Volume 62, Issue 8
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 03/2014, Volume 54, Issue 3, pp. 331 - 340
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2018, Volume 61, Issue 22, pp. 10340 - 10344
Only one FDA-approved beta-lactamase inhibitor has ever been orally available: clavulanic acid, approved in 1984. Avibactam, approved by FDA in 2015, is the... 
CEFTAZIDIME-AVIBACTAM | CHEMISTRY, MEDICINAL | DIAZABICYCLOOCTANES
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Journal Article
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 07/2018, Volume 75, Issue 13, pp. 953 - 957
PURPOSE.A patient with carbapenem-resistant Klebsiella pneumoniae infection is described, and treatment options are discussed. SUMMARY.Few antibiotics to treat... 
Carbapenem-resistant Enterobacteriaceae | Ceftazidime–avibactam | Intrathecal amikacin | CRE ventriculitis | Ventriculitis infection | INFECTIONS | ventriculitis infection | ceftazidime-avibactam | carbapenem-resistant Enterobacteriaceae | MENINGITIS | TIGECYCLINE | THERAPY | intrathecal amikacin | CEFTOLOZANE/TAZOBACTAM | FLUID | PHARMACOLOGY & PHARMACY | AGENTS | EPIDEMIOLOGY | PROGRAM | Ventriculoperitoneal Shunt | Cerebral Ventriculitis - microbiology | Injections, Intravenous | Humans | Male | Anti-Bacterial Agents - therapeutic use | Carbapenem-Resistant Enterobacteriaceae | Ventriculostomy | Adult | Azabicyclo Compounds - therapeutic use | Pseudomonas aeruginosa | Cerebral Ventriculitis - drug therapy | Drug Therapy, Combination | Injections, Spinal | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Azabicyclo Compounds - administration & dosage | Pseudomonas Infections - complications | Klebsiella Infections - complications | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cerebral Ventriculitis - surgery | Amikacin - administration & dosage | Amikacin - therapeutic use | Ceftazidime - administration & dosage | Anti-Bacterial Agents - administration & dosage | Ceftazidime - therapeutic use | Drug Combinations | Klebsiella pneumoniae | Klebsiella | Therapy | Amikacin | Central nervous system | Case reports | Cultures | Infections | Cerebrospinal fluid | Hemorrhage | Ventriculitis | Patients | Long-term care | Antibiotics | Rehabilitation | Ventricle | Emergency medical services | Ceftazidime
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2017, Volume 61, Issue 2
Journal Article
Infection, ISSN 0300-8126, 10/2018, Volume 46, Issue 5, pp. 721 - 724
The emergence of carbapenemase-producing Klebsiella pneumonia (KPC-Kp) has become a significant problem in terms of public health and clinical outcome in many... 
Ceftazidime–avibactam | Medicine & Public Health | Procalcitonin | Endocarditis | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Thrombophlebitis | Klebsiella pneumoniae | INFECTIOUS DISEASES | IMPACT | BACTEREMIA | INFECTIVE ENDOCARDITIS | SPREAD | Ceftazidime-avibactam | ENTEROBACTERIACEAE | Azabicyclo Compounds - pharmacology | Endocarditis, Bacterial - etiology | Klebsiella pneumoniae - drug effects | Ceftazidime - pharmacology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Thrombophlebitis - drug therapy | beta-Lactamases - genetics | Klebsiella pneumoniae - genetics | Thrombophlebitis - diagnosis | Azabicyclo Compounds - therapeutic use | Endocarditis, Bacterial - drug therapy | Klebsiella Infections - drug therapy | Bacterial Proteins - genetics | Endocarditis, Bacterial - diagnosis | Treatment Outcome | Klebsiella Infections - complications | Klebsiella Infections - microbiology | Bacteremia | Biomarkers | Klebsiella Infections - diagnosis | Thrombophlebitis - etiology | Ceftazidime - therapeutic use | Drug Combinations | Klebsiella | Complications and side effects | Causes of | Physiological aspects | Dosage and administration | Research | Drug therapy | Ceftazidime | Cardiovascular system | Therapy | Pneumonia | Lung | Medical services | Carbapenemase | Cultures | Infections | Ertapenem | Patients | Blood | Metastases | Abscesses | Public health | Index Medicus
Journal Article
Journal Article